Lupin, Huons ink pact for registration, marketing of Cyclosporine Ophthalmic Nanoemulsion in Mexico
Mumbai: Global pharma major Lupin Limited has announced that it has signed a license and supply agreement with Huons Co. Ltd for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion, 0.4mL Single-use Vial, in Mexico.
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for the treatment of dry eye syndrome and healing corneal ulcers. Its unique nanoparticle technology, can relieve symptoms faster by increasing the tear production in patients with suppressed tear formation due to keratoconjunctivitis sicca-related ocular inflammatory disease.
“We are delighted to partner with Huons to introduce cyclosporine ophthalmic nanoemulsion in Mexico and offer a novel technology that provides significant benefits to our patients suffering from Dry eye. With this addition to our Ophthalmology portfolio, we continue to strengthen our commitment to provide better healthcare and Eyecare solutions to our patients, improving patient quality of life and vision,” said Dr. Fabrice Egros, President – Corporate Development and Growth Markets, Lupin.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.